Lv3
270 积分 2022-06-21 加入
Advances in missing-in-metastasis research
13天前
已完结
Effect of rituximab in patients with PLA2R-associated membranous nephropathy and malignancy
18天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
1个月前
已完结
Concurrent Anti–Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series
4个月前
已完结
Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan
5个月前
已完结
Rituximab as maintenance therapy following remission induction in relapsing or refractory systemic lupus erythematosus
5个月前
已完结
Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan
8个月前
已完结
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
11个月前
已完结
Personalized phospholipase A2 receptor antibody–driven rituximab treatment strategy in membranous nephropathy
1年前
已完结
A Proposal for a Serology-Based Approach to Membranous Nephropathy
1年前
已完结
皖公网安备34019202002308
